Key takeaways Ozempic (semaglutide) has several alternatives, including other GLP-1 receptor agonists approved by the US Food and Drug Administration (FDA)
Semaglutide works by mimicking the GLP-1 hormone, which helps regulate appetite and slows gastric emptying, promoting feelings of fullness for longer periods
However, the company that makes Ozempic, Novo Nordisk, does not sell semaglutide for compounding, raising concerns about where compounded semaglutide comes from and the possible use of different formulas
Furthermore, in an ID state, the iron transport and storage functions of M2 macrophages are altered, resulting in reduced iron availability within the tumor microenvironment, further exacerbating immunosuppression and supporting tumor progression
Types of Semaglutide and Tirzepatide Shots Ozempic (Semaglutide Injection) Ozempic is a once-weekly injection of Semaglutide